D3.3 2nd Dissemination and Communication Activities

Oct 18, 2023 | Deliverables

The deliverable (D3.3) describes all Communication and Dissemination activities that have taken
place during the period 1/4/2022-30/9/2023. Scope of the activities is to maximize the impact
and the awareness of the project. All tasks have involved the whole consortium to ensure their
buy-in.
The 2 nd Dissemination and Communication Activities Report builds mostly upon all the activities
that have taken place since the beginning of the project. The deliverable is updated every one
and a half year up to now, along with the Reporting period of the project.
The report presents a detailed overview of the dissemination activities during M19-36 for the
ProCAncer-I project. It includes the objectives of the activities, target groups, promotional tools
and material, and visual identity among other strategies. All tools are being used to raise
worldwide awareness and principally act as the brand guidelines of the project. Also, the
deliverable reports all the actions that have been concluded up to M36 for the dissemination of
the project

Highlights

ProCAncer-I at the EMUC24 in Lisbon

ProCAncer-I at the EMUC24 in Lisbon

The progress of major trials, the advent of artificial intelligence (AI), and interdisciplinary best practices will comprise the scientific programme of the 16th European Multidisciplinary Congress on Urological Cancers (EMUC24), which will take place from 7 to 10...

Third Dissemination Event of the ProCAncer-I Project in Athens

Third Dissemination Event of the ProCAncer-I Project in Athens

ProCAncer-I organised the 3rd Dissemination Event of the project at the 21st IEEE International Symposium on Biomedical Imaging, held in Athens, Greece, May 27-30, 2024. During the symposium, ProCAncer-I organised the Workshop “Integrating imaging Data and AI models...

AI in PCa imaging : The current status and future perspectives

AI in PCa imaging : The current status and future perspectives

Ιn recent years, magnetic resonance imaging (MRI) has transformed the prostate cancer (PCa) diagnostic pathway, based on the evidence of multiple high-level evidence studies (refs 4M, MRI first, and PROMIS). Taken together, the evidence indicates that prostate MRI...

Open Call To Include New Beneficiaries Into The EUCAIM Consortium

Open Call To Include New Beneficiaries Into The EUCAIM Consortium

The EUCAIM project is launching an open call for new beneficiaries to join the consortium. The objective of the EUCAIM open call is to: i) onboard new cancer image data holders, increasing the geographic dimensions, data modalities or cancer targets, and  ii) include...

Twitter feed is not available at the moment.

Stay in touch!